Mild Traumatic Brain InjuryBRAIN-RESETNCT07341074
Multicenter Early Intervention Study in Adults With Complaints After Mild Traumatic Brain Injury
A study testing Treatment by physical- and/or occupational therapist and Psychoeducation via telephonic counselling in people with Mild Traumatic Brain Injury, run by University Medical Center Groningen at 1 site in Netherlands.
Trial summary
Rationale: In the Netherlands, traumatic brain injury (TBI) is one of the most frequent neurological diseases and one of the leading causes of disability. Presumably, about half of the total Dutch population will get a TBI during their lifetime. The majority, about 85%, of patients suffers from a mild TBI (mTBI). Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Mild Traumatic Brain Injury
- What is being tested?
- Treatment by physical- and/or occupational therapist and Psychoeducation via telephonic counselling
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 655 participants
- Where
- 1 siteNetherlands
- Study dates
- 16 Feb 2026to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18-70 years
- Seen at the ED within 24 hours after trauma
- Loss of consciousness (<30min.)
- Post-traumatic amnesia (<24hrs)
- Glasgow Coma Scale (GCS) score of 13-15 after initial resuscitation at the ED
- Comprehension of Dutch language
Who cannot join
- Inability for follow-up
- Chronic substance abuse (alcohol and/or drugs)
- Severe psychiatric disease
- Documented previous traumatic brain injury for which the patient was admitted
- Dementia and/or other severe comorbidities
- Current treatment by physical and/or occupational therapist for other indications
- Language barriers or illiteracy prohibiting understanding and completion of questionnaires
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
University Medical Center Groningen
Groningen
Wieke T de Jager, +31625649460, w.t.de.jager01@umcg.nl
About this study
Official title: BRAin INjury REcovery After Symptom-guided Early Therapy
Rationale: In the Netherlands, traumatic brain injury (TBI) is one of the most frequent neurological diseases and one of the leading causes of disability. Presumably, about half of the total Dutch population will get a TBI during their lifetime. The majority, about 85%, of patients suffers from a mild TBI (mTBI). The incidence of mTBI is estimated at 68,000 patients each year, but this is an underestimation as patients seen at the general practitioner's offices are not taken into account. In general, the prognosis of mTBI is relatively good, however more than 70% of patient still have one or more post-traumatic complaints at six months post-injury influencing resumption of daily (social) activities and return to work/study. Considering the high annual incidence of mTBI the number of patients with incomplete recovery has high social impact accompanied with excessive health care related costs. Post-traumatic complaints in the chronic phase postinjury are considered therapy resistant and so far no evidence based treatment is available. Hence, the most appropriate strategy is to prevent complaints present in the (sub)acute phase after injury to become persistent to improve functional outcome and quality of life.
Objective: The main aim of this study is to improve early care for patients suffering from post-traumatic complaints after mTBI through the development of effective symptom-guided tailored interventions. Nowadays, no effective therapy is available and care-as-usual consists of a wait-and-see policy. Early therapy will reduce posttraumatic complaints and facilitate earlier return to daily activities and work or study, consequently quality of life will be improved as well. This in turn will result in less healthcare consumption and lower societal costs.
Read more
Study design: The investigators propose a prospective three-arm multicenter open randomized controlled trial (RCT), randomizing participants between two interventions and care as usual. The end-point assessment is blinded.
Study population: Adults, aged 18-70 years, diagnosed with a mTBI at the Emergency Department (ED) of the participating hospitals within 24 hours after injury are eligible for inclusion.
Intervention: At two weeks post-injury the presence, severity, and type of post-traumatic complaints are assessed using the Rivermead Postconcussive complaints Questionnaire (RPQ). If a predefined minimum of complaints is present, a participant is randomised for one of the two interventions or the control group. The first intervention arm consists of symptom-targeted treatment with assignment to physical and/or occupational therapy. The second intervention arm involves psychoeducation about the complaints through telephonic counselling. The interventions are offered during three weeks from week 3-6 week post-injury.
Main study parameters/endpoints: The primary outcome measure is the total RPQ sum score at three months postinjury. The secondary outcome measures are functional outcome and quality of life.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Participants included in treatment arm 1 will undergo three to six therapy sessions with a physiotherapist and/or occupational therapist over a period of three weeks. This regimen may be potentially burdensome by its frequency but the risks associated with these treatments are low. Participants randomised to treatment arm 2 will receive three telephone calls over the course of three weeks, during which psychoeducation will be provided. This intervention is minimally burdensome and risk-free. All participants included in the interventional part of the study will complete questionnaires at three time points after injury and will receive two follow-up telephone calls three and six months post-injury for outcome assessment. This process is minimally burdensome and poses no risk. Finally, participants included in the registry will complete a limited set of questionnaires at three time points, which is also minimally burdensome and riskfree.
- Conditions
- Mild Traumatic Brain Injury
- Being tested
- Treatment by physical- and/or occupational therapist, Psychoeducation via telephonic counselling
- Medical subject headings
- Brain Concussion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Treatment by physical- and/or occupational therapistOther
Patients that are randomized in intervention arm 1 (physical- or occupational therapy) will be allocated for treatment by a physical therapist if the complaints are in the somatic domain, by an occupational therapist if the complaints are in the cognitive domain, and by both if the complaints are in both domains.
Psychoeducation via telephonic counsellingBehavioural
Patients randomised to the psychoeducation arm will be contacted by a research nurse by telephone three times between weeks 3 and 6 post-injury (approximately once per week). During the sessions, the patient's current symptoms, the expected course of recovery, and the overall favourable prognosis will be discussed based on a standardized telephone script. Reassuring information and general guidance will be provided, without the intention of inducing major behavioural change.
| Study group | Role | What they receive |
|---|---|---|
| Treatment by physical- and or occupational therapist | Experimental | Not described Receives: Other: Treatment by physical- and/or occupational therapist |
| Psychoeducation via telephonic counseling | Experimental | Not described Receives: Behavioral: Psychoeducation via telephonic counselling |
| Care as usual | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Post-traumatic complaints (measured by Rivermead Post-concussion symptoms Questionnaire, RPQ)
The RPQ is a validated questionnaire with sixteen questions assessing the presence and severity of post-traumatic complaints across somatic, cognitive, and emotional domains within the preceding 24 hours, in comparison to their pre-injury state. Responses are assigned on an ordinal scale from 0 to 4, with 0 indicating the absence of the complaint and 4 indicating a severe symptom.
Measured: Three months post-injury
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start16 Feb 2026
- Primary completion1 Oct 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mild Traumatic Brain InjuryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 655 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Medical Center Groningen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07341074
- Sponsor's protocol ID
- NL-010193
- Other IDs
- 10390032310049
- Acronym
- BRAIN-RESET
- Status last verified
- Jun 2026
- First submitted
- 5 Jan 2026
- Last updated
- 26 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- BRAin INjury REcovery After Symptom-guided Early Therapy
- ClinicalTrials.gov ID
- NCT07341074
- Acronym / sponsor ID
- BRAIN-RESET / NL-010193
- Conditions
- Mild Traumatic Brain Injury
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 655 participants (estimated)
- Lead sponsor
- University Medical Center GroningenUniversity, hospital or other
- Study start
- 16 Feb 2026 (actual)
- Primary completion
- 1 Oct 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Rationale: In the Netherlands, traumatic brain injury (TBI) is one of the most frequent neurological diseases and one of the leading causes of disability. Presumably, about half of the total Dutch population will get a TBI during their lifetime. The majority, about 85%, of patients suffers from a mild TBI (mTBI). The incidence of mTBI is estimated at 68,000 patients each year, but this is an underestimation as patients seen at the general practitioner's offices are not taken into account. In general, the prognosis of mTBI is relatively good, however more than 70% of patient still have one or more post-traumatic complaints at six months post-injury influencing resumption of daily (social) activities and return to work/study. Considering the high annual incidence of mTBI the number of patients with incomplete recovery has high social impact accompanied with excessive health care related costs. Post-traumatic complaints in the chronic phase postinjury are considered therapy resistant and so far no evidence based treatment is available. Hence, the most appropriate strategy is to prevent complaints present in the (sub)acute phase after injury to become persistent to improve functional outcome and quality of life.
Objective: The main aim of this study is to improve early care for patients suffering from post-traumatic complaints after mTBI through the development of effective symptom-guided tailored interventions. Nowadays, no effective therapy is available and care-as-usual consists of a wait-and-see policy. Early therapy will reduce posttraumatic complaints and facilitate earlier return to daily activities and work or study, consequently quality of life will be improved as well. This in turn will result in less healthcare consumption and lower societal costs.
Study design: The investigators propose a prospective three-arm multicenter open randomized controlled trial (RCT), randomizing participants between two interventions and care as usual. The end-point assessment is blinded.
Study population: Adults, aged 18-70 years, diagnosed with a mTBI at the Emergency Department (ED) of the participating hospitals within 24 hours after injury are eligible for inclusion.
Intervention: At two weeks post-injury the presence, severity, and type of post-traumatic complaints are assessed using the Rivermead Postconcussive complaints Questionnaire (RPQ). If a predefined minimum of complaints is present, a participant is randomised for one of the two interventions or the control group. The first intervention arm consists of symptom-targeted treatment with assignment to physical and/or occupational therapy. The second intervention arm involves psychoeducation about the complaints through telephonic counselling. The interventions are offered during three weeks from week 3-6 week post-injury.
Main study parameters/endpoints: The primary outcome measure is the total RPQ sum score at three months postinjury. The secondary outcome measures are functional outcome and quality of life.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Participants included in treatment arm 1 will undergo three to six therapy sessions with a physiotherapist and/or occupational therapist over a period of three weeks. This regimen may be potentially burdensome by its frequency but the risks associated with these treatments are low. Participants randomised to treatment arm 2 will receive three telephone calls over the course of three weeks, during which psychoeducation will be provided. This intervention is minimally burdensome and risk-free. All participants included in the interventional part of the study will complete questionnaires at three time points after injury and will receive two follow-up telephone calls three and six months post-injury for outcome assessment. This process is minimally burdensome and poses no risk. Finally, participants included in the registry will complete a limited set of questionnaires at three time points, which is also minimally burdensome and riskfree.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Treatment by physical- and or occupational therapist | Experimental | Other: Treatment by physical- and/or occupational therapist |
| Psychoeducation via telephonic counseling | Experimental | Behavioral: Psychoeducation via telephonic counselling |
| Care as usual | No intervention | – |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age 18-70 years
- Seen at the ED within 24 hours after trauma
- Loss of consciousness (<30min.)
- Post-traumatic amnesia (<24hrs)
- Glasgow Coma Scale (GCS) score of 13-15 after initial resuscitation at the ED
Key exclusion criteria (7 listed)
- Inability for follow-up
- Chronic substance abuse (alcohol and/or drugs)
- Severe psychiatric disease
- Documented previous traumatic brain injury for which the patient was admitted
- Dementia and/or other severe comorbidities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Treatment by physical- and/or occupational therapistPatients that are randomized in intervention arm 1 (physical- or occupational therapy) will be allocated for treatment by a physical therapist if the complaints are in the somatic domain, by an occupational therapist if the complaints are in the cognitive domain, and by both if the complaints are in both domains. | Other | Treatment by physical- and or occupational therapist |
| Psychoeducation via telephonic counsellingPatients randomised to the psychoeducation arm will be contacted by a research nurse by telephone three times between weeks 3 and 6 post-injury (approximately once per week). During the sessions, the patient's current symptoms, the expected course of recovery, and the overall favourable prognosis will be discussed based on a standardized telephone script. Reassuring information and general guidance will be provided, without the intention of inducing major behavioural change. | Behavioural | Psychoeducation via telephonic counseling |
Primary outcome
Post-traumatic complaints (measured by Rivermead Post-concussion symptoms Questionnaire, RPQ)
Time frame: Three months post-injury
The RPQ is a validated questionnaire with sixteen questions assessing the presence and severity of post-traumatic complaints across somatic, cognitive, and emotional domains within the preceding 24 hours, in comparison to their pre-injury state. Responses are assigned on an ordinal scale from 0 to 4, with 0 indicating the absence of the complaint and 4 indicating a severe symptom.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2026.
Related trials for Mild Traumatic Brain Injury
Enrolling by invitation
Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury
Concussion, Mild, Traumatic Brain Injury
Enrolling by invitation
Risk Assessment of Mild Traumatic Brain Injury in Military Training
Trauma, Brain
Not yet recruiting
Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery
Concussion (Diagnosis), Gait Abnormality
RecruitingPhase 1
Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)
Traumatic Brain Injuries, TBI (Traumatic Brain Injury)
Not yet recruitingObservational study
Cognitive Effects of Hyperbaric Oxygen Therapy (HBOT) After a Traumatic Brain Injury
Traumatic Brain Injury, Post-Concussion Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Treatment by physical- and/or occupational therapist and Psychoeducation via telephonic counselling in people with Mild Traumatic Brain Injury, run by University Medical Center Groningen at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Post-traumatic complaints (measured by Rivermead Post-concussion symptoms Questionnaire, RPQ) (time frame: Three months post-injury). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.